Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

NCT05913427 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Adrenocortical Carcinoma

Interventions

DRUG: Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG
DRUG: Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia